Abstract
The gastric toxicities of an enteric-coated formulation and conventional indomethacin were compared in rats. Both formulations were equally damaging to the mucosa, suggesting that topical damage was not the major route of injury. The importance of systemically mediated damage was further determined by gastrotoxicity dose-response curves and pyloric ligation experiments in which indomethacin was administered either orally or parenterally, or into stomach or duodenum with the pylorus occluded. Gastric damage was significantly higher in those groups that had received the drug parenterally or intraduodenally. The extent of deeper mucosal damage, assessed histologically, was greater in parenterally dosed rats. In further experiments, oral and parenteral routes of administration of two other nonsalicylate NSAIDs, naproxen and sodium diclofenac, were found to be equally damaging to the mucosa. Our results show that indomethacin-induced gastric damage, unlike aspirin injury, is mediated mainly systemically. Enteric-coating may not be a useful strategy in reducing gastric injury by nonsalicylate, nonsteroidal antiinflammatory drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Langman MJS: Epidemiologic evidence on the association between peptic ulceration and anti-inflammatory drug use. Gastroenterology 96:640–646, 1989
Holvoet J, Terriere L, Van Hee W, Verbist L, Fierens E, Hautekeete ML: Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: A case-control study. Gut 32:730–734, 1991
Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI: Gastrointestinal damage associated with the use of non-steroidal antiinflammatory drugs. N Engl J Med 327:749–754, 1992
Brodie DA, Hooke KF: Effects of route of administration on the production of gastric hemorrhage in the rat by aspirin and sodium salicylate. Dig Dis 16:985–988, 1971
Pfeiffer CJ, Lewandowski LG: Comparison of gastric toxicity of acetylsalicyclic acid with route of administration in the rat. Arch Int Pharmacodyn Ther 190:5–13, 1971
Ivey KJ, Paone DB, Krause WJ: Acute effect of systemic aspirin on gastric mucosa in man. Dig Dis Sci 25:97–99, 1980
Ligumsky M, Sestieri M, Karmeli F, Zimmerman J, Okon E, Rachmilewitz D: Rectal administration of nonsteroidal anti-inflammatory drugs. Gastroenterology 98:1245–1249, 1990
Hansen TM, Matzen P, Madsen P: Endoscopic evaluation of the effect of indomethacin capsules and suppositories on the gastric mucosa in rheumatic patients. J Rheumatol 11:484–487, 1984
Aabakken L, Bjornbeth BA, Hofstad B, Olaussen B, Larsen S, Osnes M: Comparison of the gastrointestinal side effects of naproxen formulated as plain tablets, enteric-coated tablets, or enteric-coated granules in capsules. Scand J Gastroenterol 24(suppl 163):65–73, 1989
Collins AJ, Davies J, Dixon ASJ: A prospective endoscopic study of the effect of Orudis and Oruval on the upper gastrointestinal tract in patients with osteoarthritis. Br J Rheumatol 27:106–109, 1988
Hiroshi S, Inada I, Hirata T, Maki Y: Indomethacin produces gastric antral ulcers in the refed rat. Gastroenterology 81:719–725, 1981
Hoftiezer JW, Silvoso GR, Burks M, Ivey KJ: Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 2:609–612, 1980
Lanza FL, Royer GL, Jr, Nelson RS: Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 303:135–138, 1980
Peris-Ribera JE, Torres-Molina F, Garcia-Carbonell MC, Aristorena JC, Pla-Delfina JM: Pharmacokinetics and bioavailability of diclofenac in the rat. J Pharmacokinet Biopharm 19:647–665, 1991
Runkel R, Chaplin M, Boost G, Segre E, Forchielli E: Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and man. J Pharm Sci 61:703–708, 1972
Brodie DA, Cook PG, Bauer BJ, Dagle GE: Indomethacin-induced intestinal lesions in the rat. Toxicol Appl Pharmacol 17:615–624, 1970
Djahanguiri B: The production of acute gastric ulceration by indomethacin in the rat. Scand J Gastroenterol 14:265–267, 1969
Corell T, Jensen KM: Interaction of salicylates and other non-steroidal anti-inflammatory agents in rats as shown by gastro-ulcerogenic and anti-inflammatory activities, and plasma concentrations. Acta Pharmacol Toxicol 45:225–231, 1979
Graham DY, Smith JL, Holmes GI, Davies RO: Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa. Clin Pharmacol Ther 38:65–70, 1985
Drasar BS, Hill MJ, Williams REO: The significance of gut flora in safety testing of food additives.In Metabolic Aspects of Food Safety. FJC Roe (ed). Oxford, Blackwell, 1970, pp 245–260
Hucker HB, Zacchei AG, Cox SV, Brodie DA, Cantwell NHR: Studies on the absorption, distribution and excretion of indomethacin in various species. J Pharmacol Exp Ther 153:237–249, 1966
Author information
Authors and Affiliations
Additional information
This study was supported, in part, by a grant from the National Health & Medical Research Council of Australia. M.V.S. is the recipient of a Searle Australia Pty. Ltd., Gastroenterological Society of Australia Postgraduate Scholarship.
Rights and permissions
About this article
Cite this article
Skeljo, M.V., Giraud, A.S. & Yeomans, N.D. Gastric mucosal damage induced by nonsalicylate nonsteroidal antiinflammatory drugs in rats is mediated systemically. Digest Dis Sci 38, 2038–2042 (1993). https://doi.org/10.1007/BF01297082
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01297082